Tinnitus emissions (SOAEs), which are faint high-frequency tones that are produced in the inner ear and can be measured in the ear canal with a sensitive microphone, may also cause tinnitus. About 8% of those with SOAEs and tinnitus have SOAE-linked tinnitus, while the percentage of all cases of tinnitus caused by SOAEs is estimated at about 4%. Some people experience a sound that beats in time with their pulse, known as "pulsatile tinnitus" or "vascular tinnitus". Pulsatile tinnitus is usually objective in nature, resulting from altered blood flow, increased blood turbulence near the ear, such as from atherosclerosis or venous
Tinnitus masker for hearing loss. Sound generators (masking devices) have received Class II approval from the FDA. However, they are considered to be “experimental, investigational, or unproven” therapies. There is one report of a bone conduction vibration masker that transmits a 60 Hz fundamental with adjustable harmonics up to 1000 Hz. A commercial device based on the phenomenon (Aurex3) was approved by the FDA. A new development in tinnitus management is the use of high audio (10 kHz-20 kHz) or ultrasonic (20-100 kHz) via bone conduction. A 2012 Cochrane Review stated the available studies do not show strong evidence of the efficacy